
During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
Thalidomide (Thalomid, Celgene) as a treatment for multiple myeloma
Approvable designations
Fast-track designations
Orphan drug designations
Recommendations against approval






